All-cause and cause-specific mortality in ANCA-associated vasculitis: overall and according to ANCA type

Zachary S Wallace1,2,3,4, Xiaoqing Fu1,2,3, Tyler Harkness1,2,3

  • 1Clinical Epidemiology Program, Mongan Institute.

Insights

Premature mortality in ANCA-associated vasculitis is linked to cardiovascular disease, infection, and malignancy. Patients with MPO-ANCA have a higher risk of cardiovascular death compared to PR3-ANCA patients.

Area of Science:

  • Nephrology
  • Rheumatology
  • Immunology

Background:

  • ANCA-associated vasculitis (AAV) is a group of rare autoimmune diseases characterized by inflammation of small blood vessels.
  • Understanding the causes of premature mortality in AAV is crucial for improving patient outcomes.
  • Stratifying mortality by ANCA type (MPO-ANCA vs. PR3-ANCA) may reveal distinct risk profiles.

Purpose of the Study:

  • To investigate the causes of death in a contemporary cohort of patients diagnosed with ANCA-associated vasculitis.
  • To analyze mortality patterns based on the specific type of anti-neutrophil cytoplasmic antibody (ANCA) detected.

Main Methods:

  • A consecutive inception cohort of AAV patients diagnosed between 2002 and 2017 was identified.
  • Vital status was determined using the National Death Index, and mortality incidence was calculated.
  • Standardized mortality ratios (SMRs) were compared to the general population, and Cox regression analyzed MPO-ANCA vs. PR3-ANCA cases.

Main Results:

  • The cohort comprised 484 patients; 130 deaths occurred over 3385 person-years, resulting in an SMR of 2.3.
  • Cardiovascular disease (CVD), malignancy, and infection were the leading causes of death.
  • Infection posed the greatest excess mortality risk for both MPO-ANCA and PR3-ANCA patients, while MPO-ANCA patients showed a higher risk of CVD death.

Conclusions:

  • Premature mortality in AAV is primarily attributed to CVD, infection, malignancy, and renal disease.
  • Infection represents the most significant excess mortality risk, particularly in MPO-ANCA and PR3-ANCA patients.
  • MPO-ANCA patients face a substantially higher risk of cardiovascular death compared to PR3-ANCA patients.
Abstract

Related Concept Videos

Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
160
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
234
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
819
Inflammation01:38

Inflammation

Overview
61.3K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
401